NASDAQ: BTMDBiote Corp Stock
$4.59-0.04 (-0.86%)
Updated Mar 27, 2023
BTMD Price
$4.59
Fair Value Price
N/A
Market Cap
$314.68M
52 Week Low
$2.00
52 Week High
$10.53
P/E
0.08x
P/B
-8.46x
P/S
0.13x
PEG
N/A
Dividend Yield
N/A
Revenue
$259.87M
Earnings
$131.90M
Gross Margin
66.1%
Operating Margin
52.61%
Profit Margin
50.8%
Debt to Equity
-5.9
Operating Cash Flow
$20M
Beta
-0.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BTMD Overview
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BTMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BTMD is good value based on its earnings relative to its share price (0.08x), compared to the US market average (21.44x)
P/E vs Market Valuation
BTMD is good value based on its earnings relative to its share price (0.08x), compared to the US Medical Care Facilities industry average (7.65x)
P/E vs Industry Valuation
BTMD's Earnings (EBIT) of $136.72M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more BTMD due diligence checks available for Premium users.
Be the first to know about important BTMD news, forecast changes, insider trades & much more!
BTMD News
Valuation
BTMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.08x
Industry
7.65x
Market
21.44x
BTMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BTMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BTMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-8.46x
Industry
4.61x
BTMD's financial health
Profit margin
Revenue
$42.0M
Net Income
-$13.2M
Profit Margin
-31.5%
BTMD's Earnings (EBIT) of $136.72M... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$109.6M
Liabilities
$219.5M
Debt to equity
-5.9
BTMD's short-term assets ($100.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTMD's long-term liabilities ($197.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BTMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.4M
Investing
-$387.0k
Financing
-$11.3M
BTMD's operating cash flow ($19.72M)... subscribe to Premium to read more.
Debt Coverage Financials
BTMD vs Medical Care Facility Stocks
Biote Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.